Abrdn World Healthcare Fund (NYSE:THW) Trading Down 1.9% – What’s Next?

Abrdn World Healthcare Fund (NYSE:THW) shares were down 1.9% during mid-day trading on Thursday . The company traded as low as $12.27 and last traded at $12.2750. Approximately 115,241 shares were traded during trading, a decline of 46% from the average daily volume of 211,506 shares. The stock had previously closed at $12.51.

Abrdn World Healthcare Fund Price Performance

The firm’s fifty day moving average price is $12.73 and its 200 day moving average price is $12.28.

Abrdn World Healthcare Fund Dividend Announcement

The business also recently declared a monthly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, January 23rd were paid a $0.1167 dividend. The ex-dividend date was Friday, January 23rd. This represents a c) annualized dividend and a yield of 11.4%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in THW. Newbridge Financial Services Group Inc. purchased a new stake in shares of Abrdn World Healthcare Fund in the second quarter worth about $31,000. Advisory Services Network LLC bought a new stake in Abrdn World Healthcare Fund in the 3rd quarter worth approximately $43,000. Ameriflex Group Inc. purchased a new stake in shares of Abrdn World Healthcare Fund during the 3rd quarter worth approximately $79,000. B. Riley Wealth Advisors Inc. bought a new position in shares of Abrdn World Healthcare Fund during the 2nd quarter valued at approximately $113,000. Finally, Wolverine Asset Management LLC bought a new position in shares of Abrdn World Healthcare Fund during the 4th quarter valued at approximately $170,000.

Abrdn World Healthcare Fund Company Profile

Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.

The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.